The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STW 5-II increases the relative abundances of Gram-positive anaerobes (Bifidobacteriaceae, Eggerthellaceae Lachnospiraceae, Ruminocococcaceae, Clostridiales Family XIII, and Erysipelotrichaceae) and marginally decreases the Gram-negative facultative anaerobe Enterobacteriaceae.”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [42]
In the citing paper
“These shifts improved Caco-2 cell transepithelial electrical resistance, reduced LPS-induced NF-κB signaling, and increased IL-10 production in THP1-derived macrophages [42].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
Research works printed but not linked: 42
- Asano, 2003, Permeability of the flavonoids liquiritigenin and its glycosides in licorice roots and davidigenin, a hydrogenated metabolite of liquiritigenin, using human intestinal cell line Caco-2, J. Ethnopharmacol., 89, 285, 10.1016/j.jep.2003.09.009 · DOI
- Blaženović, 2018, Software tools and approaches for compound identification of LC-MS/MS data in metabolomics, Metabolites, 8, 10.3390/metabo8020031 · DOI · Paper page
- Boon, 2003, Bioaugmentation as a tool to protect the structure and function of an activated-sludge microbial community against a 3-chloroaniline shock load, Appl. Environ. Microbiol., 69, 1511, 10.1128/AEM.69.3.1511-1520.2003 · DOI · Paper page
- Burchert, 1994, Wirkung einer fixen Kombination bei gesicherter Non-Ulcus-Dyspepsie, Zeitschrift fur Phytotherapie, 15, 24
- Canfora, 2019, Gut microbial metabolites in obesity, NAFLD and T2DM, Nat. Rev. Endocrinol., 15, 261, 10.1038/s41574-019-0156-z · DOI · Paper page
- Couteau, 2001, Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid, J. Appl. Microbiol., 90, 873, 10.1046/j.1365-2672.2001.01316.x · DOI
- De Weirdt, 2010, Human faecal microbiota display variable patterns of glycerol metabolism, FEMS Microbiol. Ecol., 74, 601, 10.1111/j.1574-6941.2010.00974.x · DOI
- Desire, 2010, Antispasmodic and antioxidant activities of fractions and bioactive constituent davidigenin isolated from Mascarenhasia arborescens, J. Ethnopharmacol., 130, 320, 10.1016/j.jep.2010.05.017 · DOI
- Elbadawi, 2021, Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids, Phytomedicine, 88, 10.1016/j.phymed.2021.153589 · DOI · Paper page
- Elbadawi, 2022, Modulation of intestinal corticotropin-releasing hormone signaling by the herbal preparation STW 5-II: possible mechanisms for irritable bowel syndrome management, Pharmaceuticals, 15, 10.3390/ph15091121 · DOI
- Feng, 2019, Gut microbiota, a new frontier to understand traditional Chinese medicines, Pharmacol. Res., 142, 176, 10.1016/j.phrs.2019.02.024 · DOI · Paper page
- Fukuda, 2011, Bifidobacteria can protect from enteropathogenic infection through production of acetate, Nature, 469, 543, 10.1038/nature09646 · DOI · Paper page
- Furrie, 2005, Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial, Gut, 54, 242, 10.1136/gut.2004.044834 · DOI · Paper page
- González-Barrio, 2011, Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies, Drug Metabol. Disposit., 39, 1680, 10.1124/dmd.111.039651 · DOI
- Klindworth, 2013, Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies, Nucleic Acids Res, 41, e1, 10.1093/nar/gks808 · DOI · Paper page
- Konishi, 2004, Microbial metabolites of ingested caffeic acid are absorbed by the Monocarboxylic Acid Transporter (MCT) in intestinal Caco-2 cell monolayers, J. Agric. Food Chem., 52, 6418, 10.1021/jf049560y · DOI
- Kroll, 2006, Pharmaceutical prerequisites for a multi-target therapy, Phytomedicine, 13, 12, 10.1016/j.phymed.2006.03.016 · DOI
- Li, 2022, Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells, BMC Vet. Res., 18, 1, 10.1186/s12917-022-03414-1 · DOI
- Lopez-Siles, 2017, Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics, ISME J., 11, 841, 10.1038/ismej.2016.176 · DOI · Paper page
- Madisch, 2004, Treatment of functional dyspepsia with a herbal preparation: a double-blind, randomized, placebo-controlled, multicenter trial, Digestion, 69, 45, 10.1159/000076546 · DOI
- Madisch, 2004, Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial, Aliment. Pharmacol. Ther., 19, 271, 10.1111/j.1365-2036.2004.01859.x · DOI · Paper page
- Meng, 2012, An investigation of the metabolism of liquiritin and the immunological effects of its metabolites, J. Liq. Chromatogr. Relat. Technol., 35, 1538, 10.1080/10826076.2011.619042 · DOI
- Monagas, 2009, Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells, Brit. J. Nutrit., 102, 201, 10.1017/S0007114508162110 · DOI
- Moorthy, 2020, Prebiotic potential of polyphenols, its effect on gut microbiota and anthropometric/clinical markers: a systematic review of randomised controlled trials, Trend. Food Sci. Technol., 99, 634, 10.1016/j.tifs.2020.03.036 · DOI
- Navarro del Hierro, 2018, The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities, J. Funct. Food., 40, 484, 10.1016/j.jff.2017.11.032 · DOI
- Possemiers, 2013, A dried yeast fermentate selectively modulates both the luminal and mucosal gut microbiota and protects against inflammation, as studied in an integrated in vitro approach, J. Agric. Food Chem., 61, 9380, 10.1021/jf402137r · DOI
- Possemiers, 2004, PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem, FEMS Microbiol. Ecol., 49, 495, 10.1016/j.femsec.2004.05.002 · DOI
- Pozuelo, 2015, Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome, Sci. Rep., 5, 10.1038/srep12693 · DOI
- Rösch, 2002, A Randomised Clinical Trial Comparing the Efficacy of a Herbal Preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia, Z. Gastroenterol., 40, 401, 10.1055/s-2002-32130 · DOI
- Roy, 2006, Short-chain fatty acids: ready for prime time?, Nutr. Clin. Pract., 21, 351, 10.1177/0115426506021004351 · DOI · Paper page
- Sasso, 2023, Gut microbiome-brain alliance: a landscape view into mental and gastrointestinal health and disorders, ACS Chem. Neurosci., 10.1021/acschemneuro.3c00127 · DOI
- Sato, 2007, Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine, Biol. Pharm. Bull., 30, 145, 10.1248/bpb.30.145 · DOI
- Schemann, 2021, Effects of the herbal preparation STW 5-II on in vitro muscle activity in the guinea pig stomach, Neurogastroenterol. Motil., 33, 1, 10.1111/nmo.13984 · DOI · Paper page
- Schneider, 2016, Anti-inflammatory effects of herbal preparations STW5 and STW5-II in cytokine-challenged normal human colon cells, Front. Pharmacol., 7, 1, 10.3389/fphar.2016.00393 · DOI
- Stevens, 2016, The chemistry of gut microbial metabolism of polyphenols, Phytochem. Rev., 15, 425, 10.1007/s11101-016-9459-z · DOI
- Thumann, 2020, Application of an in vitro digestion model to study the metabolic profile changes of an herbal extract combination by UHPLC–HRMS, Phytomedicine, 71, 10.1016/j.phymed.2020.153221 · DOI
- Tomas-Barberan, 2014, In vitro transformation of chlorogenic acid by human gut microbiota, Mol. Nutr. Food Res., 58, 1122, 10.1002/mnfr.201300441 · DOI
- Van Den Abbeele, 2018, Arabinoxylo-oligosaccharides and inulin impact inter-individual variation on microbial metabolism and composition, which immunomodulates human cells, J. Agric. Food Chem., 66, 1121, 10.1021/acs.jafc.7b04611 · DOI
- Venema, 2013, Experimental models of the gut microbiome, Best Pract. Res. Clin. Gastroenterol., 27, 115, 10.1016/j.bpg.2013.03.002 · DOI
- Wang, 1995, Gastrointestinal absorption characteristics of glycyrrhizin from Glycyrrhiza extract, Biol. Pharm. Bull., 18, 1238, 10.1248/bpb.18.1238 · DOI
- Wei, 2018, Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10, Appl. Microbiol. Biotechnol., 102, 9193, 10.1007/s00253-018-9285-x · DOI
- Yang, 2015, The pharmacological activities of licorice, Planta Med., 81, 1654, 10.1055/s-0035-1557893 · DOI
Cited by
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1
Metadata
- Authors
- Ammar, R., Pferschy-Wenzig, E., Van den Abbeele, P., Verstrepen, L., Ghyselinck, J., Thumann, T., & Bauer, R.
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 119
- Pages
- 154996
- ISSN
- 0944-7113
- Cited by
- 24
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Steigerwald Arzneimittelwerk GmbH
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health. https://app.cochat.ai/papers/10.1016/j.phymed.2023.154996
- The paper
- Ammar, R., Pferschy-Wenzig, E., Van den Abbeele, P., Verstrepen, L., Ghyselinck, J., Thumann, T., & Bauer, R. (2023). Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.154996
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.